Sean Ferree

Factors Predicting Late Recurrence for Estrogen Receptor–Positive Breast Cancer

Jack Cuzick, Ivana Sestak, Mitch Dowsett, 2013, Journal of the National Cancer Institute.

Development of Gene Expression-Based Biomarkers on the nCounter® Platform for Immuno-Oncology Applications.

Sean Ferree, Sarah Warren, Patrick Danaher, 2020, Methods in molecular biology.

PAM50 Risk of Recurrence Score Predicts 10-Year Distant Recurrence in a Comprehensive Danish Cohort of Postmenopausal Women Allocated to 5 Years of Endocrine Therapy for Hormone Receptor-Positive Early Breast Cancer.

Sean Ferree, T. Nielsen, S. Ferree, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Analytical validation of the PAM50-based Prosigna Breast Cancer Prognostic Gene Signature Assay and nCounter Analysis System using formalin-fixed paraffin-embedded breast tumor specimens

Sean Ferree, Dongxia Gao, Brett Wallden, 2014, BMC Cancer.

Comparison of PAM50 risk of recurrence score with oncotype DX and IHC4 for predicting risk of distant recurrence after endocrine therapy.

Jack Cuzick, Ivana Sestak, Mitch Dowsett, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.